BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28770326)

  • 1. The effects of metformin on gut microbiota and the immune system as research frontiers.
    Pollak M
    Diabetologia; 2017 Sep; 60(9):1662-1667. PubMed ID: 28770326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and gut microbiota: their interactions and their impact on diabetes.
    Vallianou NG; Stratigou T; Tsagarakis S
    Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota compositions and metabolic functions in type 2 diabetes differ with glycemic durability to metformin monotherapy.
    Hung WW; Peng P; Tsai YC; Jhou PS; Chang CC; Hsieh CC; Su YC; Dai CY; Hung WC
    Diabetes Res Clin Pract; 2021 Apr; 174():108731. PubMed ID: 33676995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
    Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
    Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
    Zhang X; Zhao Y; Xu J; Xue Z; Zhang M; Pang X; Zhang X; Zhao L
    Sci Rep; 2015 Sep; 5():14405. PubMed ID: 26396057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
    Mardinoglu A; Boren J; Smith U
    Cell Metab; 2016 Jan; 23(1):10-2. PubMed ID: 26771114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
    Maniar K; Moideen A; Bhattacharyya R; Banerjee D
    Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota.
    Zheng J; Li H; Zhang X; Jiang M; Luo C; Lu Z; Xu Z; Shi J
    J Agric Food Chem; 2018 Jun; 66(23):5821-5831. PubMed ID: 29701959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin effect on gut microbiota: insights for HIV-related inflammation.
    Ouyang J; Isnard S; Lin J; Fombuena B; Marette A; Routy B; Chen Y; Routy JP
    AIDS Res Ther; 2020 Mar; 17(1):10. PubMed ID: 32156291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials.
    Pietroiusti A; Magrini A; Campagnolo L
    Toxicol Appl Pharmacol; 2016 May; 299():90-5. PubMed ID: 26723910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
    Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
    PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
    Maniar K; Moideen A; Mittal A; Patil A; Chakrabarti A; Banerjee D
    Pharmacol Res; 2017 Mar; 117():103-128. PubMed ID: 27939359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on the gut microbiota: A systematic review.
    Pavlo Petakh ; Kamyshna I; Kamyshnyi A
    Mol Metab; 2023 Nov; 77():101805. PubMed ID: 37696355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
    Swanson HI
    Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota: Antidiabetic drug treatment confounds gut dysbiosis associated with type 2 diabetes mellitus.
    Holmes D
    Nat Rev Endocrinol; 2016 Feb; 12(2):61. PubMed ID: 26668122
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of metformin action: In and out of the gut.
    Minamii T; Nogami M; Ogawa W
    J Diabetes Investig; 2018 Jul; 9(4):701-703. PubMed ID: 29777629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaproteomics Reveals Growth Phase-Dependent Responses of an
    Hao Z; Li L; Ning Z; Zhang X; Mayne J; Cheng K; Walker K; Liu H; Figeys D
    J Am Soc Mass Spectrom; 2020 Jul; 31(7):1448-1458. PubMed ID: 32320607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
    Koopen AM; Groen AK; Nieuwdorp M
    Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.